Literature DB >> 4086970

Estimating the sensitivity of a screening test.

N E Day.   

Abstract

A commonly used estimate of a screening test's sensitivity, based on the prevalence at screening and the incidence of interval cancers, is shown to be logically unsound and quantitatively poor. An alternative simple estimate is proposed, based only on incidence rates.

Entities:  

Mesh:

Year:  1985        PMID: 4086970      PMCID: PMC1052473          DOI: 10.1136/jech.39.4.364

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  3 in total

1.  Estimation of the duration of a pre-clinical disease state using screening data.

Authors:  S D Walter; N E Day
Journal:  Am J Epidemiol       Date:  1983-12       Impact factor: 4.897

2.  Simplified models of screening for chronic disease: estimation procedures from mass screening programmes.

Authors:  N E Day; S D Walter
Journal:  Biometrics       Date:  1984-03       Impact factor: 2.571

3.  Repeated screening for breast cancer.

Authors:  J Chamberlain; R E Clifford; B E Nathan; J L Price; I Burn
Journal:  J Epidemiol Community Health       Date:  1984-03       Impact factor: 3.710

  3 in total
  19 in total

Review 1.  Design of cancer screening trials/randomized trials for evaluation of cancer screening.

Authors:  Anthony B Miller
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

Review 2.  Current issues and future perspectives of gastric cancer screening.

Authors:  Chisato Hamashima
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 3.  Benefits and harms of endoscopic screening for gastric cancer.

Authors:  Chisato Hamashima
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  False negative rate in cervical cytology.

Authors:  Y van der Graaf; G P Vooijs
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

5.  Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.

Authors:  C T Brekelmans; P Westers; J A Faber; P H Peeters; H J Collette
Journal:  J Epidemiol Community Health       Date:  1996-02       Impact factor: 3.710

6.  Age-specific sensitivities of mammographic screening for breast cancer.

Authors:  P G Peer; A L Verbeek; H Straatman; J H Hendriks; R Holland
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Performance measures in three rounds of the English bowel cancer screening pilot.

Authors:  S M Moss; C Campbell; J Melia; D Coleman; S Smith; R Parker; P Ramsell; J Patnick; D P Weller
Journal:  Gut       Date:  2011-05-10       Impact factor: 23.059

8.  Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years.

Authors:  S Moss; I Thomas; A Evans; B Thomas; L Johns
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

9.  Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location.

Authors:  L Guittet; V Bouvier; N Mariotte; J P Vallee; R Levillain; J Tichet; G Launoy
Journal:  Br J Cancer       Date:  2009-03-31       Impact factor: 7.640

10.  Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography.

Authors:  Y Toyoda; T Nakayama; Y Kusunoki; H Iso; T Suzuki
Journal:  Br J Cancer       Date:  2008-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.